Steven D. Ertel is COO & VP at ACCELERON PHARMA INC (XLRN). They have made 5 open-market trades across 1 company since 2014, most recently 2017-03-02.
CIK 0001280600
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| XLRN | 136,977 | $24.5M |
Shares reported on the most recent Form 4, priced at the 2017-03-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XLRN | SELL | 2017-01-04 | 2017-01-06 | $27.44 | $69K | -9.2% | -11.0% | -3.4% |
| XLRN | SELL | 2016-07-05 | 2016-07-06 | $32.89 | $114K | -6.1% | -4.7% | +2.1% |
| XLRN | SELL | 2016-07-01 | 2016-07-06 | $34.77 | $984K | -6.1% | -4.7% | +2.1% |
| XLRN | SELL | 2016-07-01 | 2016-07-06 | $34.56 | $1.1M | -6.1% | -4.7% | +2.1% |
| XLRN | SELL | 2016-04-07 | 2016-04-08 | $32.00 | $1.0M | -3.2% | -2.1% | +7.8% |
| XLRN | SELL · 10b5-1 | 2015-09-15 | 2015-09-16 | $33.61 | $67K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-08-17 | 2015-08-19 | $30.46 | $61K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-07-15 | 2015-07-17 | $31.38 | $63K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-06-15 | 2015-06-16 | $31.11 | $62K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-05-15 | 2015-05-18 | $31.49 | $63K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-04-15 | 2015-04-17 | $33.58 | $67K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-03-04 | 2015-03-06 | $40.96 | $205K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-02-02 | 2015-02-04 | $38.69 | $193K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-01-15 | 2015-01-16 | $40.58 | $81K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-01-02 | 2015-01-05 | $38.47 | $192K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-12-01 | 2014-12-02 | $35.87 | $269K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-11-12 | 2014-11-14 | $33.14 | $331K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-10-01 | 2014-10-01 | $29.66 | $297K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-08-14 | 2014-08-15 | $29.78 | $298K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-07-01 | 2014-07-02 | $34.09 | $341K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-06-02 | 2014-06-04 | $29.72 | $297K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-05-19 | 2014-05-21 | $31.52 | $315K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-04-22 | 2014-04-24 | $35.87 | $90K | -30.5% | -6.3% | -6.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.